Peptide-based immunotherapeutic agent for treating allergic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/35 (2006.01) C07K 14/415 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2248937

The present invention provides a monomolecular multi-epitope peptide prepared by binding T cell epitope regions derived from different allergen molecules with each other. A peptide-based immunotherapeutic agent containing an effective amount of the multi-epitope peptide can prevent and treat a wide range of allergic diseases.

Cette invention concerne un agent immunothérapeutique à base peptidique contenant une quantité efficace d'un peptide multi-épitope monomoléculaire que l'on prépare en liant entre elles des régions d'épitopes de lymphocytes T dérivées de différentes molécules d'allergène. Ledit agent est efficace s'agissant de la prévention et du traitement d'un grand nombre d'allergies diverses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide-based immunotherapeutic agent for treating allergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide-based immunotherapeutic agent for treating allergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-based immunotherapeutic agent for treating allergic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1999337

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.